List of SBIR/STTR awards granted to PDX Pharmaceuticals, Inc.
PDX Pharmaceuticals, Inc.A SBIR Phase II contract was awarded to PDX Pharmaceuticals, Inc. in September, 2021 for $1,898,361.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to PDX Pharmaceuticals, Inc. in September, 2021 for $378,030.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to PDX Pharmaceuticals, Inc. in June, 2018 for $1,507,301.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to PDX Pharmaceuticals, Inc. in May, 2017 for $224,965.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to PDX Pharmaceuticals, Inc. in August, 2017 for $325,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to PDX Pharmaceuticals, Inc. for $200,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to PDX Pharmaceuticals, Inc. for $1,000,000.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to PDX Pharmaceuticals, Inc. for $299,741.0 USD from the U.S. Department of Health & Human Services.
